Monday, December 22, 2025
HomeIndustriesBiotechnology

Biotechnology

BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA)...

PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company

PolarityTE, Inc., a biotechnology company developing regenerative tissue products and biomaterials announced that it signed a non-binding letter of intent (the "LOI") with Michael...

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative drug discovery platform, announced that the...

Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that for the first time, a...

New Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal Implant

Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience repairing the esophagus after the cancer in the patient's esophagus had been surgically removed*...
0FansLike
0FollowersFollow
spot_img

Hot Topics